Nodal status in the papillary thyroid vancer. Comparison of the results of routine histopathological examination, immunohistochemistry and reverse transcription - Polymerase chain reaction

Neoplasma

Volumn 55, Issue 6, 2008, Pages 513-518

  Kaczka, K ^a,b   Jakubiak Wielganowicz, M ^a,c   Zawlik, I ^a   Ziolkowski, R ^a,b   Kuzdak, K ^a   Pomorski, L ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Memorial Copernicus Hospital ^*  (Poland)

^c Memorial Copernicus Hospital   (Poland)

Author keywords

Histopathological examination immunohistochemistry; Lymph node metastases; Reverse transcription polymerase chain reaction; Thyroid cancer

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; COMPARATIVE STUDY; CYTOCHEMISTRY; EVALUATION; LYMPH NODE METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 59749093645     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. KEBEBEW E., CLARK O. Differentiated Thyroid Cancer, Complete Rational Approach, World Surg. 2000; 24: 942-951.
2. HAY I.D. Papillary thyroid carcinoma, Endocrinol Metab Clin North Am., 1990; 19: 545-576 .
3. BELLANTONE R, LOMBARDI R, BOSCHERINI M. et al. Prognostic Factors in Differentiated Thyroid Carcinoma: Multivariate Analysis of 234 Consecutive Patients, Surg Oncol. 1998; 68: 237-241. (Pubitemid 28390179)
4. GAGEL R.F, GOEPFERT H, CALLENDER DL. Changing Concepts in the Pathogenesis and Management of Thyroid Carcinoma, Ca Cancer Journal for Clinicians 1996; 46: 261-283. (Pubitemid 26343454)
5. BEASLEY NJ, LEE J, ESKI S et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer, Arch Otolaryngolog Head Neck Surg. 2002; 128: 825-828 (Pubitemid 34755316)
6. BHATTACHARYYA N. population-based analysis of survival factors in differentiated and medullary thyroid carcinoma, Otolaryngolog Head Neck Surg. 2003; 128: 115-123 (Pubitemid 36246129)
7. STEINMULLER T, KLUPP J, RAYES N et al. Prognostic factors in patients with differentiated thyroid carcinoma, Eur Surg. 2002; 166: 29-33
8. WARD LS, SOUZA SL. The Impact of Nodal Metastases on Prognosis of Well-Differentiated Thyroid Cancer Suggests the Practice of Prophylactic, Arch Otolaryngolog Head Neck Surg. 2003; 9: 495-496
9. MUSSACCHIO MJ, KIM AW, VIJUNGCO JD. Greater Local Reccurence Occurs with Berry Picking than Neck Dissection in Thyroid Cancer, Am Surg. 2003 69: 191-196
10. SIMON D, GORETZKI PE, WITTE J et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma, World Surg. 1996; 20: 860-866
11. MOSS TJ, SANDERS DG. Detection of neuroblastoma cells in blood, Journal of Oncology 1990 8: 736-740
12. STAHEL RA, MABRY M, SKARIN AT et al. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody, Clin Oncol. 1985; 3: 455-461 (Pubitemid 15111391)
13. KIRK SJ, COOPER GG, HOPER M et al. Odling-Smee, W.: The prognostic significance of marrow micrometastases in women with early breast cancer, Eur Surg Oncol. 1990; 16: 481-485
14. REDDING WH, COOMBES RC, MONAGHAN P et al. Detection of micrometastases in patients with primary breast cancer, Lancet 1983; 3: 1271-1274 (Pubitemid 14242918)
15. WEBER T, AMANN K, WECKAUF H. Detection of Disseminated Medullary Thyroid Carcinoma Cells in Cervical Lymph Nodes by Cytokeratin 20 Reverse Transcription-Polymerase Chain Reaction, World Surg. 2002; 26: 148-152
16. WEITZ J, KIENLE P, MAGENER et al. Detection of Disseminated Colorectal Cancer Cells in Lymph Nodes, Blood and Bone Marrow, Cancer Res. 1999; 5: 1830-1836
17. FUTAMURA M, YAKAGI Y, HOUMURA H. Spread of Colorectal Cancer Micrometastases in Regional Lymph Nodes by Reactions for Carcinoembryonic Antigen and Cytokeratin 20, Surg Oncol. 1998; 68: 34-40.
18. WEBER T, KLAR E. Minimal Residual Disease in Thyroid Carcinoma, Semin Surg Oncol., 2002; 20: 272-277
19. MULLIS KB, FALOONA FA. Specific synthesis of DNA in vitro via polymerase-catalyzed chain reaction, Methods Enzymol. 1987; 155: 335-350.
20. GHOSSEIN RA. Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors, Cancer Res. 1999; 5: 1950-1960. (Pubitemid 29399243)
21. LIEFERS GJ, CLETON-JANSEN AM, van de VELDE CJ, et al. Micrometastases and survival in stage II colorectal cancer, Eng Med. 1998; 339: 223-228. (Pubitemid 28350164)
22. WEITZ J, KIENLE P, LACROIX P et al. Dissemination of Tumor Cells in Patients Undergoing Surgery for Colorectal Cancer, Cancer Res. 1998; 4: 343-348. (Pubitemid 28122748)
23. SEELIGER H, SPATZ H, JAUCH KW. Minimal Residual Disease in Gastric Cancer, Recent Results in Cancer Res. 2003; 162: 79-87.
24. WASCHER RA, BOSTICK PJ, HUYNH KT et al. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes, J Cancer 2001; 85: 1340-1346. (Pubitemid 33081930)
25. BOSTICK PJ, CHATTER J, CHI DD et al. Limitations of Specific RT-PCR Markers in the Detection of Metastases in the Lymph Nodes and Blood of Breast Cancer Patients, Clin Oncol. 1998; 16: 2632-2640.
26. TABACK B, CHAN AD, KUO CT et al. Detection of Occult Metastatic Breast Cancer Cells in Blood by Multimolecular Marker Assay, Cancer Res. 2001; 61: 8845-8850.
27. WANG X, HELLER R, VANVOORHIS N et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma, Ann Surg. 1994; 220: 768-774.
28. SMITH B, SELBY P, SOUTHGATE J et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction, Lancet 1991; 338:1227-1229.
29. DEMEURE M, DOFFEK K, KOMOROWSKI R, WILSON S. Adenocarcinoma of the Pancreas- detection of occult metastases in lymph nodes by polymerase chain reaction- bassed assay, Cancer 1998; 83: 1328-1334. (Pubitemid 28460083)
30. NAGATAKI S, NYSTRÖM E. Epidemiology and Primary Prevention of Thyroid Cancer. Thyroid 2002, 12: 889-896. (Pubitemid 35332993)
31. WITTE J, GORETZKI PE, DICKEN J et al. Importance of lymph node metastases in follicular thyroid cancer, World Surg. 2002; 26: 1017-1022. (Pubitemid 36920302)
32. POMORSKI L, CYWIŃSKI J, KOLOMECKI K et al. Recurrences of thyroid cancer after radical surgery and complementary treatment: are macroscopic, microscopic, scintigraphic, and biochemical criteria sufficient in the evaluation of radicality of primary treatment? Recent Results in Cancer Res. 2003; 162: 203-207.
33. POMORSKI, L, KACZKA K, PIASKOWSKI S et al. Detection of lymph node metastases of papillary thyroid cancercomparison of the results of histopathology, immuhistochemistry and reverse transcription- polymerase chain reaction- preliminary report, Langenbecks Arch Surg 2005; 390: 209-215.
34. SOBIN LH, WITTEKIND CH editors. TNM Classification of Malignant Tumours. New York: Willey-Liss, 2002.
35. SPIESSL B, BEAHRS OH, HERMANEK P, editors. TNMAtlas. Berlin-Heidelberg: Springer, 1993.
36. ROBBINS KT, MEDIMA JE, WOLFE GT. Standarizing Neck Dissection Terminology, Arch Otolaryngolog Head Neck Surg. 1991; 117: 601-605.
37. KUS J, OSMÓLSKI A, FRENKIEL Z et al. Classification of the neck dissections (article in Polish), Otolaryngol Pol. 2000; 54: 129-132.
38. DRALLE H, GIMM O. Lymphadenektomie beim Schilddrüsencarcinom, Chirurg 1996; 67: 788-806.
39. KULAKOWSKI A. Thyroid neoplasms. In: Szawlowski AW, Szmidt J, editors. The rules of diagnostics and surgical treatment of neoplasms in Poland (book in Polish). Warsaw: Fundacja-Polski Przeglad Chirurgiczny, 2003: 127-139.
40. GUSTERSON B, OTT R. Occult axillary lymph-node metastases in breast cancer, Lancet 1990; 336: 434-435. (Pubitemid 20252465)
41. KEENE SA, DEMEURE MJ. The clinical significance of micrometastases and molecular metastases, Surgery 2001; 129: 1-5. (Pubitemid 32099250)
42. MATEJKOWSKA-SOBANIEC M, PASIEKA Z, POMORSKI L. Papillary microcarcinoma of the thyroid gland in light of consecutive histopathological examinations, Pol Przegl Chir. 2005; 77: 691-702.
43. GUSTERSON B. Are micrometastasis clinically relevant? Br Hosp Med. 1991; 47: 247-252.
44. PARGAONKAR AS, BEISSNER RS, SNYDER S et al. Evaluation of immunohistochemistry and multi-level sectioning in sentinel lymph nodes from patients with breast cancer, Arch Pathol Lab Med. 2003; 127: 701-705. (Pubitemid 36613221)
45. BILCHIK AJ, SAHA S, WIESE D et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: multicenter phase II trial, Clin Oncol. 2001; 19: 1128-1136.
46. ROMA A, ALVAREZ C, PAES DE LIMA A et al. Detection of micrometastases of colorectal carcinoma in lymph nodes, Medicina 2003; 63: 399-402. (Pubitemid 37407951)
47. LOCKETT MA, BARON PL, O'BRIEN PH et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using multimarker reverse transcriptase- polymerase chain reaction panel, Journal of American College of Surgeon 1998; 187: 9-16.
48. KIJIMA F, NATSUGOE S, TAKAO S et al. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription- polymerase chain reaction in patients with esophageal carcinoma, Oncology 2000; 58: 38-44. (Pubitemid 30045308)
49. BLAHETA HJ, SCHITTEK B, BREUNINGER H et al. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry, Int Cancer 1998; 79: 318-323.
50. GUBALA E, HANDKIEWICZ-JUNAK D, ZEMAN M et al. Thyroglobulin RT-PCR method for detection of lymph node metastases during the course of differentiated thyroid cancer, Wiad Lek. 2001; 54: 349-356.
51. VENKATRAMAN L, MAXWELL P, McCLUGGAGE WG. Thyroglobulin immunoreactivity in lymph node histiocytes: potential diagnostic pitfall, Clin Pathol. 2001; 54: 314-316
52. HURTEAU GJ, SPIVACK SD. mRNA specific reverse transcription- polymerase chain reaction from human tissue extracts, Annal Biochem. 2002; 307: 304-315. (Pubitemid 35026205)
53. CHELLY J, CONCORDET JP, KAPLAN JC. Illegitimate transcription: Transcription of any gene in any cell type, Biochemistry 1989; 86: 2617-2621. (Pubitemid 19112598)
54. COOPER DN, BERG LP, KAKKAR VV et al. Ectopic illegitimate transcription: new possibilities for the analysis and diagnosis of human genetic disease, Annal Med. 1994; 26: 9-14.
55. AUST G, CRISP M, BOSENBERG E. Transcription of thyroid autoantigens in non-expressing tissues, Exp Clin Endocrinol Diabetes 1998; 106: 319-323.
56. BOJUNGA J, RÖDDIGER S, STANISCH M et al. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR, Br Cancer 2000; 82: 1650-1655.
57. TSUJIMOTO M, NAKABAYASHI K, YOSHIDOME K et al. One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients, Clin Cancer Res 2007; 13: 4807-4816.